What’s the American Heart Association’s position?
We have a task force that examines the medical support for new and unestablished therapies, of which chelation is one. The report of the task force was adopted by the American Heart Association as our official policy statement on chelation therapy. This report states: The American Heart Association’s Clinical Science Committee has reviewed the available literature on the use of chelation (EDTA) in the treatment of arteriosclerotic heart or blood vessel disease and finds no scientific evidence to demonstrate any benefit of this form of therapy. Furthermore, employment of this form of unproven treatment may deprive patients of the well-established benefits attendant to the many other valuable methods of treating these diseases. What do other authorities say about this treatment? Food and Drug Administration: In the absence of evidence of safety and effectiveness, the use of this treatment for atherosclerosis is investigational. To date, no physician or sponsor has filed a plan or protoco
